Related Experiment Videos
Is health economics useful in cancer?
1Cochrane Cancer Network, Institute of Health Sciences, Oxford, UK.
Critical Reviews in Oncology/Hematology
|August 10, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Causal Pivot: A structural approach to genetic heterogeneity and variant discovery in complex diseases.
American journal of human genetics·2025
Eliciting the impacts of cellular noise on metabolic trade-offs by quantitative mass imaging.
Nature communications·2019
Biomarker-Guided Treatment Selection in Metastatic Colorectal Cancer: A Critical Review of Established and Emerging Therapies.
Critical reviews in oncology/hematology·2026
TREM2⁺ tumor-associated macrophages in cancer: context-dependent biology, biomarkers and precision immunotherapy.
Critical reviews in oncology/hematology·2026
Lipid Metabolic Reprogramming in Colorectal Cancer: A Central Hub Integrating Diet, Microenvironment, and Therapy Resistance.
Critical reviews in oncology/hematology·2026
Clinical Management of Oral Potentially Malignant Disorders: State of the Art Review and Proposal for a New Framework.
Critical reviews in oncology/hematology·2026
Targeting intracellular immune regulatory molecules for cancer immunotherapy in solid tumors.
Critical reviews in oncology/hematology·2026
Spatial Heterogeneity in Anaplastic Thyroid Carcinoma: Mechanistic Insights and Clinical Translation through Single-Cell and Spatial Transcriptomics.
Critical reviews in oncology/hematology·2026
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.
Journal of comparative effectiveness research·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026